GOSS first to 3 then to 15With the aid of high volume I suppose GOSS will reach 2024 max fist than 2024 max is on the way.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.3178 USD
−179.82 M USD
0.00 USD
174.03 M
About Gossamer Bio, Inc.
Sector
CEO
Faheem Hasnain
Headquarters
San Diego
Website
Founded
2015
FIGI
BBG00MVWLLM2
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.
GOSS - long - bottom & gap playGossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth,
GOSS Penny Biotechology SHORTGOSS is a biotechnology penny stock without earnings valued based on future earnings
potential based on a "pipeline" which is subject to a long timeline of FDA regulation.
On the 30 minute chart. price is shown as being in the overvalued area in the upper VWAP
band and well above the POC line
GOSS - short squeeze - phase 2 catalystThis is not a financial advice!
Upcoming catalyst and block buys recently.
SL under 0.97
Key level: 1.4 must be broken and hold for bullish confirmation.
TP 1 around 3.0
TP 2 around 6.0
TP 3 around 9.0
Only 89.93M float
18.97% Short float
Most info on the chart.
Trade carefully!
Oversold, good buy opportunityThere is a good buy opportunity when you look at daily or weekly graphs.it is oversold and rsi is at the bottom.
Minimum Target for the next 20-30 days around $3 $4
Biotechs are on fire! Gossamer and upcoming event! Biotechnology is the favorite sector of one of our analysts, most of his portfolio consists of biotechs, and he himself claims that it is the cryptocurrency of the common stock market.
Why? Let's explain :
High risk/reward and high volatility.
Imagine this: you invest in a company that has no
GOSS Rally ?This stock jumped to the top of my proprietary algorithm about 2 weeks ago; set the alert and it fired a few days ago.
The chart shown is as simple as it gets; see expected price action on chart and be sure to review the comments box.
Set your alerts, stop loss, etc. as needed.
Feedback always welco
LONG-TERM PLAYI have 2 versions of this chart to publish; this is the complex visual that includes all of the channel color-coded.
See comments on the chart for details.
LONG-TERM PLAYI have 2 versions of this chart to publish; this is the simple visual.
See comments on the chart for details.
Gossamer Bio longGossamer Bio
Healthcare
Biotechnology
USA
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States and is headquartered in San D
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GOSS is 0.8400 USD — it has decreased by −0.11% in the past 24 hours. Watch Gossamer Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Gossamer Bio, Inc. stocks are traded under the ticker GOSS.
GOSS stock has fallen by −9.68% compared to the previous week, the month change is a 18.26% rise, over the last year Gossamer Bio, Inc. has showed a −1.66% decrease.
We've gathered analysts' opinions on Gossamer Bio, Inc. future price: according to them, GOSS price has a max estimate of 15.00 USD and a min estimate of 4.00 USD. Watch GOSS chart and read a more detailed Gossamer Bio, Inc. stock forecast: see what analysts think of Gossamer Bio, Inc. and suggest that you do with its stocks.
GOSS reached its all-time high on Dec 12, 2019 with the price of 27.1497 USD, and its all-time low was 0.4525 USD and was reached on Oct 24, 2023. View more price dynamics on GOSS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GOSS stock is 7.56% volatile and has beta coefficient of 1.52. Track Gossamer Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Gossamer Bio, Inc. there?
Today Gossamer Bio, Inc. has the market capitalization of 190.35 M, it has increased by 22.44% over the last week.
Yes, you can track Gossamer Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Gossamer Bio, Inc. is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
GOSS earnings for the last quarter are −0.14 USD per share, whereas the estimation was −0.15 USD resulting in a 4.86% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about Gossamer Bio, Inc. earnings.
Gossamer Bio, Inc. revenue for the last quarter amounts to 9.48 M USD, despite the estimated figure of 8.53 M USD. In the next quarter, revenue is expected to reach 6.83 M USD.
GOSS net income for the last quarter is −30.80 M USD, while the quarter before that showed 49.23 M USD of net income which accounts for −162.57% change. Track more Gossamer Bio, Inc. financial stats to get the full picture.
No, GOSS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 135.00 employees. See our rating of the largest employees — is Gossamer Bio, Inc. on this list?
Like other stocks, GOSS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gossamer Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Gossamer Bio, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Gossamer Bio, Inc. stock shows the sell signal. See more of Gossamer Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.